This company seems to have been delisted
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
Reason: Acquired by Amgen
Last recorded trade on: November 25, 2022
Source: https://www.amgen.com/newsroom/press-releases/2022/08/amgen-to-acquire-chemocentryx-for-$4-billion-in-cash
ChemoCentryx
CCXI
$69.96
Share price
0.00%
Change (1 day)
33.35%
Change (1 year)
Categories
Earnings for ChemoCentryx (CCXI)
Earnings in 2022 (TTM): -S$0.18 Billion
According to ChemoCentryx's latest financial reports the company's current earnings are S$37.2 Million. In 2021 the company made an earning of -S$0.18 Billion a decrease over its 2020 earnings that were of -S$70.94 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for ChemoCentryx from 2011 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2022 (TTM)  | -S$0.18 Billion | 2.53% |
| 2021 | -S$0.18 Billion | 144.84% |
| 2020 | -S$70.94 Million | -1.18% |
| 2019 | -S$71.78 Million | 45.17% |
| 2018 | -S$49.45 Million | -305.69% |
| 2017 | S$24.03 M | -144.7% |
| 2016 | -S$53.78 Million | -15.52% |
| 2015 | -S$63.66 Million | 0.85% |
| 2014 | -S$63.12 Million | 21.47% |
| 2013 | -S$51.97 Million | -1.24% |
| 2012 | -S$52.62 Million | 906.88% |
| 2011 | -S$5.23 Million |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | S$2.56 B | -1,559.42% | 🇺🇸 USA |
 | S$5.00 B | -2,945.33% | 🇺🇸 USA |
 | S$5.91 B | -3,464.89% | 🇬🇧 UK |
 | -S$11.28 Billion | 6,315.77% | 🇺🇸 USA |
 | S$23.47 B | -13,455.28% | 🇺🇸 USA |
 | S$6.20 B | -3,629.10% | 🇺🇸 USA |
 | S$14.95 B | -8,609.19% | 🇺🇸 USA |
 | -S$0.38 Billion | 115.93% | 🇮🇱 Israel |
 | S$28.53 B | -16,338.13% | 🇺🇸 USA |